Related Experiment Video

Updated: May 31, 2026

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach
11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Structure-based discovery of novel flavonol inhibitors of human protein kinase CK2

Andriy G Golub1, Volodymyr G Bdzhola, Yaroslav V Kyshenia

  • 1Institute of Molecular Biology and Genetics of National Academy of Sciences of Ukraine, 150 Zabolotnogo Str., Kyiv 03143, Ukraine. andrew.golub@gmail.com

Molecular and Cellular Biochemistry
|July 8, 2011
PubMed

Insights

Novel 3-hydroxy-4'-carboxyflavones show high inhibitory activity against protein kinase CK2. These findings highlight potential new pharmaceutical agents for treating cancer and inflammatory diseases.

Area of Science:

  • Biochemistry
  • Medicinal Chemistry
  • Molecular Biology

Background:

  • Protein kinase CK2 (CK2) is crucial for cellular processes but its exact functions remain unclear.
  • CK2 activity is linked to various diseases, suggesting its potential as a therapeutic target.
  • CK2 inhibitors are being explored for cancer, viral, and inflammatory disease treatments.

Purpose of the Study:

  • To synthesize and evaluate novel flavonol derivatives as CK2 inhibitors.
  • To investigate the structure-activity relationships of these compounds.
  • To develop a binding model for their interaction with the CK2 ATP-binding site.

Main Methods:

  • Combinatorial organic synthesis of 3-hydroxy-4 -carboxyflavones.
  • Molecular modeling techniques.
  • Biochemical in vitro assays to determine inhibitory activity.

Main Results:

  • The novel synthetic 3-hydroxy-4 -carboxyflavones demonstrated high inhibitory activity against CK2.
  • Structure-activity relationship analysis provided insights into key interactions.
  • A binding model was developed, elucidating interactions within the CK2 ATP-binding site.

Conclusions:

  • 3-hydroxy-4 -carboxyflavones are potent CK2 inhibitors.
  • These compounds represent promising candidates for developing new therapeutic agents.
  • The study advances understanding of CK2 inhibition mechanisms.

More Related Videos

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays13:22

Kinase Inhibitor Screening In Self-assembled Human Protein Microarrays

Published on: October 23, 2019

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a polypeptide...